Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 5/20 | 0.70 |
| ▸ | GCGR | P47871 | 3/20 | 0.70 |
| ▸ | NMBR | P28336 | 2/20 | 0.69 |
| ▸ | GRPR | P30550 | 2/20 | 0.69 |
| ▸ | CTSL | P07711 | 3/20 | 0.64 |
| ▸ | CTSS | P25774 | 3/20 | 0.64 |
| ▸ | CTSK | P43235 | 3/20 | 0.64 |
| ▸ | CTSH | P09668 | 1/20 | 0.62 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.62 |
| ▸ | CALCA | P06881 | 2/20 | 0.61 |
| ▸ | NPY1R | P25929 | 1/20 | 0.61 |
| ▸ | NPY2R | P49146 | 1/20 | 0.61 |
| ▸ | NPY4R | P50391 | 1/20 | 0.61 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.61 |
| ▸ | CALCR | P30988 | 1/20 | 0.61 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.60 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31083828 | 1.00 | GLP1R (0.70) | GLP1RGCGRNMBRGRPRCTSL | |
| SCHEMBL29462210 | 0.94 | NMBR (0.77) | GLP1RGCGRNMBRGRPRC5AR1 | |
| SCHEMBL29367990 | 0.94 | CALCA (0.69) | GLP1RGCGRGRPRCALCANPY1R | |
| SCHEMBL23273229 | 0.93 | NMBR (0.69) | GLP1RGCGRNMBRGRPRCTSL | |
| SCHEMBL30932062 | 0.89 | GLP1R (0.74) | GLP1RGCGRNMBRGRPRC5AR1 | |
| SCHEMBL29599666 | 0.89 | GLP1R (0.70) | GLP1RGCGRNMBRGRPRC5AR1 | |
| SCHEMBL20764721 | 0.88 | GRPR (0.70) | GLP1RGCGRNMBRGRPRCTSL | |
| SCHEMBL6689263 | 0.88 | GLP1R (0.69) | GLP1RGCGRC5AR1CALCANPY1R | |
| SCHEMBL31182829 | 0.88 | GLP1R (0.73) | GLP1RGCGRC5AR1NPY1RNPY2R | |
| SCHEMBL30932061 | 0.88 | GLP1R (0.72) | GLP1RGCGRCALCANPY1RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 688 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115724949-B | Murine lgG monoclonal antibody and preparation method and application thereof | 郑州伊美诺生物技术有限公司 | 2026-05-15 | — | — | CN | claimed |
| US-12491258-B2 | Method for preparing long-acting drug conjugate through preparation of intermediate | HANMI PHARM. CO., LTD. (KR) | 2025-12-09 | — | — | US | claimed |
| US-20250345325-A1 | BIOMARKERS FOR THE DIAGNOSIS AND TREATMENT OF FIBROTIC LUNG DISEASE | UNIV COLORADO REGENTS (US) | 2025-11-13 | — | — | US | claimed |
| US-12390533-B2 | Protein complex comprising non-peptidyl polymer-coupled fatty acid derivative compound as linker and preparation method therefor | HANMI PHARM. CO., LTD. (KR) | 2025-08-19 | — | — | US | claimed |
| US-20250250321-A1 | Multifunctional Multispecific Multimeric Biomolecule Polymer Having Prolonged In-Vivo Duration | ONEGENE BIOTECHNOLOGY INC. (KR) | 2025-08-07 | — | — | US | claimed |
| CN-120137027-A | Anti-gastrin releasing peptide precursor antibodies and uses thereof | 东莞市朋志生物科技有限公司 | 2025-06-13 | — | — | CN | claimed |
| CN-120137026-A | Anti-gastrin releasing peptide precursor antibodies and uses thereof | 东莞市朋志生物科技有限公司 | 2025-06-13 | — | — | CN | claimed |
| EP-4556488-A2 | NOVEL METHOD FOR PREPARING LONG-ACTING DRUG CONJUGATE THROUGH PREPARATION OF INTERMEDIATE | Hanmi Pharm. Co., Ltd. (KR) | 2025-05-21 | — | — | EP | claimed |
| EP-4555516-A1 | METHODS AND SYSTEMS FOR MALIGNANCY PREDICTION OF INDETERMINATE PULMONARY NODULES | Abbott Laboratories (US) | 2025-05-21 | — | — | EP | claimed |
| EP-4001303-B1 | METHOD FOR PREPARING LONG-ACTING DRUG CONJUGATE THROUGH PREPARATION OF NOVEL INTERMEDIATE | HANMI PHARMACEUTICAL CO LTD (KR) | 2025-05-07 | — | — | EP | claimed |
| CN-114605537-A | Anti-gastrin releasing peptide antibody, detection reagent and kit | 东莞市朋志生物科技有限公司 | 2022-06-10 | — | — | CN | claimed |
| WO-2022114838-A1 | NOVEL BRAIN-TARGETING, LONG-ACTING PROTEIN CONJUGATE AND PREPARATION METHOD THEREFOR | 한미약품 주식회사 | 2022-06-02 | — | — | WO | claimed |
| EP-4001303-A1 | METHOD FOR PREPARING LONG-ACTING DRUG CONJUGATE THROUGH PREPARATION OF NOVEL INTERMEDIATE | Hanmi Pharm. Co., Ltd. (KR) | 2022-05-25 | — | — | EP | claimed |
| US-20220133839-A1 | PEPTIDE ANALOGUES WITH BRANCHED AMINO ACID PROBE(S) | TXP PHARMA GMBH (CH) | 2022-05-05 | — | — | US | claimed |
| CN-108743967-B | Pharmaceutical composition containing immunoglobulin FC region as carrier | 韩美科学株式会社 | 2022-04-26 | — | — | CN | claimed |
| CN-114152742-A | Kit for light-activated chemiluminescence immunoassay containing magnetic luminescent microspheres and application thereof | 深圳市易瑞生物技术股份有限公司 | 2022-03-08 | — | — | CN | claimed |
| CN-109239348-B | Antibody for gastrin-releasing peptide precursor detection kit and kit | 北京科卫临床诊断试剂有限公司 | 2022-03-08 | — | — | CN | claimed |
| CN-114062665-A | Tracer particle marked target molecule and preparation method and application thereof | 菲鹏生物股份有限公司 | 2022-02-18 | — | — | CN | claimed |
| WO-2022032353-A1 | RADIOPHARMACEUTICALS, USES THEREOF, AND METHODS FOR THE PRODUCTION THEREOF | Clarity Pharmaceuticals Ltd (AU) | 2022-02-17 | — | — | WO | claimed |
| CN-114040779-A | Conjugates of cell binding molecules containing branched linkers and cytotoxic agents | 杭州多禧生物科技有限公司 | 2022-02-11 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12390533-B2 | Protein complex comprising non-peptidyl polymer-coupled fatty acid derivative compound as linker and preparation method therefor | FABP1, FABP4, FABP7 | GLP1R 463/4885GCGR 914/4885NMBR 1860/4885 |
| US-12491258-B2 | Method for preparing long-acting drug conjugate through preparation of intermediate | GNRHR, UGT1A7, UGT1A3 | GLP1R 35/4885GCGR 97/4885NMBR 600/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.